
Invitae Corporation NVTA
Quartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Invitae Corporation P/CF 2011-2026 | NVTA
P/CF Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.04 | -4.24 | -22.3 | -10.8 | -9.52 | -3.11 | -3.13 | -2.27 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.04 | -22.3 | -7.05 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
BioNano Genomics
BNGO
|
-0.0515 | $ 1.12 | -0.88 % | $ 1.42 M | ||
|
Brainsway Ltd.
BWAY
|
271 | $ 24.41 | 1.2 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 27.63 | -4.06 % | $ 297 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Celcuity
CELC
|
-4.78 | $ 105.79 | 0.61 % | $ 4.17 B | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Danaher Corporation
DHR
|
23.3 | $ 209.19 | - | $ 149 B | ||
|
DarioHealth Corp.
DRIO
|
-1.43 | $ 11.26 | - | $ 319 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 23.09 | 0.35 % | $ 698 M | ||
|
Co-Diagnostics
CODX
|
-1.58 | - | - | $ 79.8 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
14.3 | $ 209.54 | - | $ 23.3 B | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 29.94 | 3.46 % | $ 832 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-28.3 | $ 19.25 | 2.45 % | $ 1.03 B | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
DexCom
DXCM
|
17.7 | $ 73.09 | -0.23 % | $ 28.5 B | ||
|
Interpace Biosciences
IDXG
|
0.888 | $ 1.74 | -5.95 % | $ 7.63 M | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | $ 103.45 | 0.06 % | $ 19.5 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 287.13 | 0.64 % | $ 23.9 B | ||
|
Guardant Health
GH
|
-72.7 | $ 95.4 | 1.04 % | $ 12 B | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 166.06 | - | $ 8.23 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.43 | 1.14 % | $ 410 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 104.09 | -0.54 % | $ 8.59 B | ||
|
ENDRA Life Sciences
NDRA
|
-0.297 | $ 3.86 | 2.93 % | $ 2.07 M | ||
|
IDEXX Laboratories
IDXX
|
43.3 | $ 649.23 | 4.19 % | $ 52.2 B | ||
|
Illumina
ILMN
|
19.6 | $ 122.9 | 1.96 % | $ 19.5 B | ||
|
Natera
NTRA
|
-12.3 | $ 209.53 | 0.09 % | $ 20.6 B | ||
|
IQVIA Holdings
IQV
|
10.7 | $ 164.88 | - | $ 28.3 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
29.7 | $ 1 379.66 | - | $ 28.4 B | ||
|
Biodesix
BDSX
|
-1.89 | $ 13.02 | 1.96 % | $ 1.69 B | ||
|
Quidel Corporation
QDEL
|
18.7 | $ 21.93 | 3.49 % | $ 924 M | ||
|
Pacific Biosciences of California
PACB
|
-5.45 | $ 1.66 | 5.06 % | $ 421 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 31.5 | 0.9 % | $ 20 B | ||
|
Lantheus Holdings
LNTH
|
11.9 | $ 73.61 | 0.26 % | $ 5.09 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.1 | - | $ 4.82 M |